| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/08/2007 | US20070032425 Compositions for diabetes treatment and prophylaxis |
| 02/08/2007 | US20070032424 Stimulators of Factor X activated (FXa) as new topical antihemorrhagic agents |
| 02/08/2007 | US20070032423 Methods and compositions for modulating somatolactogenic functions |
| 02/08/2007 | US20070032422 Methods, compositions and articles of manufacture for contributing to the treatment of cancers |
| 02/08/2007 | US20070032421 Methods and compositions relating to cystatin C |
| 02/08/2007 | US20070032420 Treating diabetes with glucagon-like peptide-1 secretagogues |
| 02/08/2007 | US20070032419 Fusion polypeptide, which comprise a peptide of 3-30 amino acids, which permits the fusion polypeptide to be bound selectively to tumor vessel endothelial cells, and the tissue factor or a fragment thereof; enables the fusion polypeptide to be bound selectively to tumor vessel endothelial cells |
| 02/08/2007 | US20070032418 Small-molecule inhibitors of angiogenin and rnases and in vivo and in vitro methods of using same |
| 02/08/2007 | US20070032417 Peptides and therapeutic uses thereof |
| 02/08/2007 | US20070032416 Chorionic somatomammotropin hormone splice variants |
| 02/08/2007 | US20070032415 Compositions, splice variants and methods relating to breast specific genes and proteins |
| 02/08/2007 | US20070032414 Human secreted proteins |
| 02/08/2007 | US20070032413 Of given amino acid sequence; vectors, host cells, and recombination; diagnosing and treating diseases related to human secreted proteins |
| 02/08/2007 | US20070032412 Particularly Kahalalide F, a tridecapeptide with a ring shape side and a lateral side amidated with 5-methylhexanoic acid; 650 mu g/m2/day administered intravenously in cycles of 1-4 weeks |
| 02/08/2007 | US20070032411 Protein kinase signalling |
| 02/08/2007 | US20070032410 Compositions and methods for the treatment of psychiatric disorders |
| 02/08/2007 | US20070032409 Bradykinin receptor antagonists and uses thereof |
| 02/08/2007 | US20070032408 Novel spacer moiety for poly (ethylene glycol) modified peptide based compounds |
| 02/08/2007 | US20070032407 Use treating hepatitis C infection optionally with other viricides such as interferons or ribavirin; low toxicity to the host; use of cytosine-based nucleotides or nucleosides having a 2'-trifluoromethyl-ribose moiety which forms a 5'-phosphate or hydroxy moiety in vivo |
| 02/08/2007 | US20070032406 Identification of novel nogo-receptors and methods related thereto |
| 02/08/2007 | US20070032405 Branched water-soluble polymers and their conjugates |
| 02/08/2007 | US20070032404 Methods for treating diabetes and related disorders using pde10a inhibitors |
| 02/08/2007 | US20070032403 Crystal structure of the ITK kinase domain |
| 02/08/2007 | US20070032153 Altering the polarity of surfaces with amphipathic peptides |
| 02/08/2007 | US20070031967 Hyperactive, non-phosphorylated, mutant transposases of mariner mobile genetic elements |
| 02/08/2007 | US20070031965 Chimeric molecules that contain at least one pathogen-detection domain and at least one effector domain; use in preventing or treating a pathogen infection in a cell or organism |
| 02/08/2007 | US20070031945 High mannose proteins and methods of making high mannose proteins |
| 02/08/2007 | US20070031938 Organic anion transporting (oat)-like protein ust3-like1 and uses thereof |
| 02/08/2007 | US20070031929 Polypeptides Homologous To VEGF and BMP1 |
| 02/08/2007 | US20070031925 Small molecular weight TNF receptor multimeric molecule |
| 02/08/2007 | US20070031909 identifying a compound that modulates methylation of a protein phosphatase that affects a protein activity and determining that the protein activity is altered by modulating with the compound methylation of the protein phosphatase |
| 02/08/2007 | US20070031907 Anaplastic lymphoma kinase assay, reagents and compositions thereof |
| 02/08/2007 | US20070031904 Mammalian IAP gene family, primers, probes and detection methods |
| 02/08/2007 | US20070031903 Mammalian IAP gene family, primers, probes and detection methods |
| 02/08/2007 | US20070031899 Using serine/threonine kinase Pim-1 polypeptide phosphorylation inhibition after exposure to modulator as indication of antitumor/cancer activity; treating pancreatic cancer |
| 02/08/2007 | US20070031888 Human leucine-rich repeat containing protein expressed predominately in small intestine, HLRRSI1 |
| 02/08/2007 | US20070031882 Methods and compositions for treating AIDS and HIV-related disorders using 1414, 1481,1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784 or 2045 molecules |
| 02/08/2007 | US20070031878 Methods and compositions for polypeptide engineering |
| 02/08/2007 | US20070031864 Polyvalent cation-sensing receptor in atlantic salmon |
| 02/08/2007 | US20070031860 G-protein coupled receptor and uses therefor |
| 02/08/2007 | US20070031835 Diagnosis of advanced cancer |
| 02/08/2007 | US20070031524 Food compositions comprising waterleaf leaves and methods of using thereof |
| 02/08/2007 | US20070031516 Composition for the prevention and treatment of cellulitis |
| 02/08/2007 | US20070031511 Method of treatment |
| 02/08/2007 | US20070031506 Interleukin-18 inducer |
| 02/08/2007 | US20070031502 Pharmaceutical composition for the treatment of acute disorders |
| 02/08/2007 | US20070031500 Long-acting solid formulation comprising triptorelin acetate |
| 02/08/2007 | US20070031485 Pharmaceutical composition having a cationic excipient |
| 02/08/2007 | US20070031484 Immunoliposomes that optimize internationalization into target cells |
| 02/08/2007 | US20070031478 Modified peptides and their uses |
| 02/08/2007 | US20070031474 Biocompatible, biodegradable globins modified by acetylation, succinylationor esterification; soluble at physioloical pH; grafting; powder, granules, film, membrane, mesh, sponge and preformed implant, or in paste, gel, or suspension form; prosthetics |
| 02/08/2007 | US20070031465 Implant for regenerating bone or cartilage with the use of transcriptional factor |
| 02/08/2007 | US20070031460 micelles; cyclosporin A solubilized via fatty acid and/or fatty alcohol |
| 02/08/2007 | US20070031452 rheumatoid arthritis; nervous system disorders; endogenous retroviral elements (ERV) |
| 02/08/2007 | US20070031445 Compositions and methods for enhancing immune responses mediated by antigen-presenting cells |
| 02/08/2007 | US20070031443 Methods for treating or preventing skin disorders using CD2-binding agents |
| 02/08/2007 | US20070031439 Novel protein related to melanoma-inhibiting protein and uses thereof |
| 02/08/2007 | US20070031435 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 02/08/2007 | US20070031434 Uses for Eph receptor antagonists and agonists |
| 02/08/2007 | US20070031420 MASP-2, a complement-fixing enzyme, and uses for it |
| 02/08/2007 | US20070031412 using activated factor X (FXa) effector; hemorrhagic diathesis; cardiovascular disorders |
| 02/08/2007 | US20070031405 Use of A33 antigens and jam-it |
| 02/08/2007 | US20070031401 Metalloprotease catalytic site for use in identifying modulators for prevention and treatment of respiratory system disorders |
| 02/08/2007 | US20070031400 Dichloroacetate in combination with clinically high levels of cardioprotective or hemodynamic drugs |
| 02/08/2007 | US20070031399 Use of proline specific endoproteases to hydrolyse peptides and proteins |
| 02/08/2007 | US20070031398 One of several enzyme-containing compounds, dietetic food products and drugs produced from and the use therefor for medical purpose |
| 02/08/2007 | US20070031397 Compositions and methods for enhancing axon regeneration |
| 02/08/2007 | US20070031396 Method of treating neurological diseases |
| 02/08/2007 | US20070031395 Repressor of skeletal muscle differentiation, nucleic acid coding therefor and the use thereof in diagnosis and therapy |
| 02/08/2007 | US20070031394 Method of treating neurological disorders |
| 02/08/2007 | US20070031391 Using genetically engineered neural stem cells to track metastatic brain tumor cells by migrating throughout a brain tumor; antitumor agents |
| 02/08/2007 | US20070031389 Using cardiac graft to treat and prevent scar tissue on heart; tissue engineering and regenerative medicine |
| 02/08/2007 | US20070031383 Recombinant herpes simplex virus useful for treating neoplastic disease |
| 02/08/2007 | US20070031381 Recombinant adenoviral vector and method of use |
| 02/08/2007 | US20070031377 Treatment of type 1 immune response-mediated inflammatory lung disease by modulation of ifn-gamma activity |
| 02/08/2007 | US20070031376 In which IL-6R and IL-6 are directly linked without a linker; blood platelet proliferating agent, ex vivo amplifier for hematopoietic stem cells |
| 02/08/2007 | US20070031375 IL-16 antagonist peptides and DNA encoding the peptides |
| 02/08/2007 | US20070031374 Treating cell proliferative disorders via administration of mixture comprising interleukin-21 and anti-cancer monoclonal antibody |
| 02/08/2007 | US20070031373 Reversal of Adult Onset Disorders with Granulocyte-Colony Stimulating Factors |
| 02/08/2007 | US20070031372 Vaccine immunotherapy for immune suppressed patients |
| 02/08/2007 | US20070031368 Chemokine conjugates |
| 02/08/2007 | US20070031364 Keratin gel and the types 2,4 and 6 of collagens of frog protein topical use or for lamina preparation use, such as dressing powdering in food and complements use and in cosmetic mask manufacturing or in solutions used in cosmetic formulation and medical/pharmaceutical |
| 02/08/2007 | US20070031351 DNA sequences encoding novel growth/differentiation factors |
| 02/08/2007 | US20070031342 Sustained release microparticles for pulmonary delivery |
| 02/08/2007 | US20070031341 Methods of delivering therapeutics to the brain |
| 02/08/2007 | US20070031335 Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers |
| 02/08/2007 | US20070031332 Angiogenic agents from plant extracts, gallic acid, and derivatives |
| 02/08/2007 | US20070031331 Treatment of Disorders |
| 02/08/2007 | DE19858005B4 Synthetisches Nucleinsäure-Partikel Synthetic nucleic acid particles |
| 02/08/2007 | DE102005036542A1 CTL-Prodrug CTL prodrug |
| 02/08/2007 | CA2633755A1 Antifungal peptides and methods of use thereof |
| 02/08/2007 | CA2617534A1 Lipidated tissue factor and factor xa as a new topical anti-hemorrhagic agent |
| 02/08/2007 | CA2617294A1 Substituted ethane-1,2-diamines for the treatment of alzheimer's disease ii |
| 02/08/2007 | CA2617226A1 Method of preserving the function of insulin-producing cells |
| 02/08/2007 | CA2617095A1 Macrocylic inhibitors of hepatitis c virus |
| 02/08/2007 | CA2616987A1 Mutated pseudomonas exotoxins with reduced antigenicity |
| 02/08/2007 | CA2616912A1 Use of the globular domain of acrp30 for the preparation of a medicament for the prevention and/or treatment of thrombosis-related diseases |
| 02/08/2007 | CA2616525A1 Novel biologically active peptides and their new uses |
| 02/08/2007 | CA2615666A1 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 02/08/2007 | CA2613327A1 Method of treating patients with a mucinous glycoprotein (muc-1) vaccine |